相关实验视频
Updated: Jan 15, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
分子诊断和个性化疗法在差异化甲状腺癌:一个临床导向的审查
Andrés Coca-Pelaz1, Juan Pablo Rodrigo1, Mark Zafereo2
1Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.
分子诊断和个性化疗法正在改善差异化甲状腺癌 (DTC) 管理. 精准医学策略,包括向治疗,为侵袭性或耐治疗性甲状腺癌病例提供了新的希望.
科学领域:
- 内分泌学和瘤学 在内分泌学和瘤学.
- 分子诊断学 分子诊断
- 精准医学是一门精准的医学.
背景情况:
- 分化甲状腺癌 (DTC) 是最常见的内分泌恶性瘤,预后通常有利.
- 一小部分DTC患者呈现出侵袭性疾病,复发或对标准治疗的抵抗,需要先进的策略.
- 目前的管理依赖于风险分层,但分子洞察力对于个性化护理至关重要.
研究的目的:
- 提供对DTC分子诊断和个性化治疗的临床重点审查.
- 综合关键遗传改变对诊断,预后和治疗的影响.
- 探索分子标记物融入临床决策和DTC精密瘤学的未来方向.
主要方法:
- 关于DTC分子分析的当前文献的叙事综述.
- 检查基因变异及其临床相关性.
- 针对性疗法和精准医学实施中的挑战的讨论.
主要成果:
- 分子分析增强了DTC的传统风险分层,指导了手术决策,放射性 (RAI) 的使用和监测.
- 向治疗,包括氨酸激酶抑制剂,显示出希望,特别是在RAI耐火DTC.
- 关键的遗传变化具有重要的诊断,预后和治疗影响.
结论:
- 分子诊断和个性化治疗正在改变DTC管理.
- 精准医学方法,由遗传洞察力提供信息,对于优化DTC的治疗和结果至关重要.
- 未来的进展,如液体活检和AI集成,将进一步个性化DTC护理.
更多相关视频
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Cancer
Therapeutic Drug Monitoring: Overview and Classification